These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 32248854)

  • 1. A potential protective role of losartan against coronavirus-induced lung damage.
    Zeinalian M; Salari-Jazi A; Jannesari A; Khanahmad H
    Infect Control Hosp Epidemiol; 2020 Jun; 41(6):752-753. PubMed ID: 32248854
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19 and Renin Angiotensin Blockers: Current Evidence and Recommendations.
    Messerli FH; Siontis GCM; Rexhaj E
    Circulation; 2020 Jun; 141(25):2042-2044. PubMed ID: 32282224
    [No Abstract]   [Full Text] [Related]  

  • 3. Imatinib for COVID-19: A case report.
    Morales-Ortega A; Bernal-Bello D; Llarena-Barroso C; Frutos-Pérez B; Duarte-Millán MÁ; García de Viedma-García V; Farfán-Sedano AI; Canalejo-Castrillero E; Ruiz-Giardín JM; Ruiz-Ruiz J; San Martín-López JV
    Clin Immunol; 2020 Sep; 218():108518. PubMed ID: 32599278
    [No Abstract]   [Full Text] [Related]  

  • 4. Audio Interview: Acute Lung Injury in Covid-19.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Jul; 383(2):e32. PubMed ID: 32640146
    [No Abstract]   [Full Text] [Related]  

  • 5. RAAS blockers in hypertension posing a higher risk toward the COVID-19.
    Singh Y; Gupta G; Satija S; Negi P; Chellappan DK; Dua K
    Dermatol Ther; 2020 Jul; 33(4):e13501. PubMed ID: 32359088
    [No Abstract]   [Full Text] [Related]  

  • 6. The Potential Benefit of Telmisartan to Protect Overweight Patients with COPD from the Acquisition of COVID-19.
    Kow CS; Hasan SS
    Obesity (Silver Spring); 2020 Nov; 28(11):2035. PubMed ID: 32692903
    [No Abstract]   [Full Text] [Related]  

  • 7. Should we unstress SARS-CoV-2 infected cells?
    Csukasi F; Rico G; Becerra J; Duran I
    Cytokine Growth Factor Rev; 2020 Aug; 54():3-5. PubMed ID: 32563554
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
    Costiniuk CT; Jenabian MA
    Cytokine Growth Factor Rev; 2020 Jun; 53():63-65. PubMed ID: 32467020
    [No Abstract]   [Full Text] [Related]  

  • 9. COVID-19, Angiotensin Receptor Blockers, and the Brain.
    Saavedra JM
    Cell Mol Neurobiol; 2020 Jul; 40(5):667-674. PubMed ID: 32385549
    [No Abstract]   [Full Text] [Related]  

  • 10. Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome.
    van de Veerdonk FL; Netea MG; van Deuren M; van der Meer JW; de Mast Q; Brüggemann RJ; van der Hoeven H
    Elife; 2020 Apr; 9():. PubMed ID: 32338605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renin-angiotensin system and SARS-CoV-2 interaction: underlying mechanisms and potential clinical implications.
    Hrenak J; Zorad S; Simko F
    Gen Physiol Biophys; 2020 May; 39(3):203-204. PubMed ID: 32525813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of angiotensin II blockers on the prognosis of COVID-19: a toxicological view.
    Shirazi FM; Banerji S; Nakhaee S; Mehrpour O
    Eur J Clin Microbiol Infect Dis; 2020 Oct; 39(10):2001-2002. PubMed ID: 32557325
    [No Abstract]   [Full Text] [Related]  

  • 13. COVID-19, pulmonary mast cells, cytokine storms, and beneficial actions of luteolin.
    Theoharides TC
    Biofactors; 2020 May; 46(3):306-308. PubMed ID: 32339387
    [No Abstract]   [Full Text] [Related]  

  • 14. COVID-19 and lung pathology.
    Jain A
    Indian J Pathol Microbiol; 2020; 63(2):171-172. PubMed ID: 32317509
    [No Abstract]   [Full Text] [Related]  

  • 15. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: Is immunosuppression a risk factor for SARS-COV2 infection?
    Sereno M; Gutiérrez-Gutiérrez G; Sandoval C; Falagan S; Jimenez-Gordo AM; Merino M; López-Menchaca R; Martínez-Martin P; Roa S; Casado E
    Lung Cancer; 2020 Jul; 145():213-215. PubMed ID: 32389426
    [No Abstract]   [Full Text] [Related]  

  • 16. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung.
    Dastan F; Abedini A; Shahabi S; Kiani A; Saffaei A; Zare A
    Iran J Allergy Asthma Immunol; 2020 May; 19(S1):10-12. PubMed ID: 32534505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Coronavirus Pneumonia and Cardiomyopathy: A Case Report.
    Huyut MA
    Arq Bras Cardiol; 2020 Jun; 114(5):843-845. PubMed ID: 32491076
    [No Abstract]   [Full Text] [Related]  

  • 18. Lopinavir/ritonavir did not shorten the duration of SARS CoV-2 shedding in patients with mild pneumonia in Taiwan.
    Cheng CY; Lee YL; Chen CP; Lin YC; Liu CE; Liao CH; Cheng SH
    J Microbiol Immunol Infect; 2020 Jun; 53(3):488-492. PubMed ID: 32331982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?
    Şen S; Üresin AY
    Turk Kardiyol Dern Ars; 2020 Oct; 48(7):631-634. PubMed ID: 33034579
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19, Arrhythmic Risk, and Inflammation: Mind the Gap!
    Lazzerini PE; Boutjdir M; Capecchi PL
    Circulation; 2020 Jul; 142(1):7-9. PubMed ID: 32286863
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.